Spinal cord injury (SCI) remains the most serious complication of repairing descending thoracic and thoracoabdominal aortic aneurysms, with endovascular ...

India’s transcatheter aortic valve replacement (TAVR) market is projected to grow at a compound annual growth rate of around 24% until 2033.

GlobalData’s latest report reveals that India accounted for only around 3 per cent of the market in APAC in 2024, due to ...

Edwards Lifesciences Corp.’s posted fourth quarter results slightly ahead of expectations, but indicated that the first quarter of 2025 might not be as bright. The company expects growth for both its ...

Overall, Edwards enjoys a great deal of financial flexibility that would allow for more substantial acquisitions, if those opportunities were to arise. Edwards Lifesciences has come to dominate ...

Edwards Lifesciences stock popped Wednesday on strong sales of its TAVR procedures, leading to a top- and bottom-line beat.

Executives expect a new label indication and a hoped-for easing of hospital capacity constraints to accelerate sales this ...